Jonathan Haddad Borowsky

Mr. Jonathan Haddad Borowsky

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2021 in Nature Chemistry
Verified
Journal Article
Open access
PDF file
MZMaxwell I. Zimmerman
Maxwell I. Zimmerman
JPJustin R. Porter
Justin R. Porter
MWMichael D. Ward
Michael D. Ward
SSSukrit Singh
Sukrit Singh
NVNeha Vithani
Neha Vithani
GBGregory R. Bowman
Gregory R. Bowman
SARS-CoV-2 has intricate mechanisms for initiating infection, immune evasion/suppression and replication that depend on the structure and dynamics of its constituent proteins. Many protein structures have been solved, but far less is known about their relevant conformational changes. To address this challenge, over a million citizen scientists banded together through the Folding@home distributed computing project to create the first exascale computer and simulate 0.1 seconds of the viral proteome. Our adaptive sampling simulations predict dramatic opening of the apo spike complex, far beyond that seen experimentally, explaining and predicting the existence of ‘cryptic’ epitopes. Different spike variants modulate the probabilities of open versus closed structures, balancing receptor binding and immune evasion. We also discover dramatic conformational changes across the proteome, which reveal over 50 ‘cryptic’ pockets that expand targeting options for the design of antivirals. All data and models are freely available online, providing a quantitative structural atlas.

1 July 2021 in Biophysical Journal
Verified
Journal Article
Open access
NVNeha Vithani
Neha Vithani
MWMichael D. Ward
Michael D. Ward
MZMaxwell I. Zimmerman
Maxwell I. Zimmerman
BNBorna Novak
Borna Novak
JBJonathan Haddad Borowsky
Jonathan Haddad Borowsky
GBGregory R. Bowman
Gregory R. Bowman
Coronaviruses have caused multiple epidemics in the past two decades, in addition to the current COVID-19 pandemic that is severely damaging global health and the economy. Coronaviruses employ between twenty and thirty proteins to carry out their viral replication cycle including infection, immune evasion, and replication. Among these, nonstructural protein 16 (Nsp16), a 2’-O-methyltransferase, plays an essential role in immune evasion. Nsp16 achieves this by mimicking its human homolog, CMTr1, which methylates mRNA to enhance translation efficiency and distinguish self from other. Unlike human CMTr1, Nsp16 requires a binding partner, Nsp10, to activate its enzymatic activity. The requirement of this binding partner presents two questions that we investigate in this manuscript. First, how does Nsp10 activate Nsp16? While experimentally-derived structures of the active Nsp16/Nsp10 complex exist, structures of inactive, monomeric Nsp16 have yet to be solved. Therefore, it is unclear how Nsp10 activates Nsp16. Using over one millisecond of molecular dynamics simulations of both Nsp16 and its complex with Nsp10, we investigate how the presence of Nsp10 shifts Nsp16’s conformational ensemble in order to activate it. Second, guided by this activation mechanism and Markov state models (MSMs), we investigate if Nsp16 adopts inactive structures with cryptic pockets that, if targeted with a small molecule, could inhibit Nsp16 by stabilizing its inactive state. After identifying such a pocket in SARS-CoV2 Nsp16, we show that this cryptic pocket also opens in SARS-CoV1 and MERS, but not in human CMTr1. Therefore, it may be possible to develop pan-coronavirus antivirals that target this cryptic pocket.

29 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
AMArtur Meller
Artur Meller
MWMichael Ward
Michael Ward
JBJonathan Haddad Borowsky
Jonathan Haddad Borowsky
JLJeffrey M. Lotthammer
Jeffrey M. Lotthammer
MKMeghana Kshirsagar
Meghana Kshirsagar
GBGregory R. Bowman
Gregory R. Bowman
Cryptic pockets expand the scope of drug discovery by enabling targeting of proteins currently considered undruggable because they lack pockets in their ground state structures. However, identifying cryptic pockets is labor-intensive and slow. The ability to accurately and rapidly predict if and where cryptic pockets are likely to form from a protein structure would greatly accelerate the search for druggable pockets. Here, we present PocketMiner, a graph neural network trained to predict where pockets are likely to open in molecular dynamics simulations. Applying PocketMiner to single structures from a newly-curated dataset of 39 experimentally-confirmed cryptic pockets demonstrates that it accurately identifies cryptic pockets (ROC-AUC: 0.87) >1,000-fold faster than existing methods. We apply PocketMiner across the human proteome and show that predicted pockets open in simulations, suggesting that over half of proteins thought to lack pockets based on available structures are likely to contain cryptic pockets, vastly expanding the druggable proteome.

Verified
Journal Article
Open access
PDF file
JBJonathan Haddad Borowsky
Jonathan Haddad Borowsky
MGMichael Grabe
Michael Grabe
The inner mitochondrial membrane proteins ATP/ADP carrier protein 1 (AAC1) and Uncoupling protein 1 (UCP1) belong to the SLC25 mitochondrial carrier family. AAC1 is responsible for ATP/ADP exchange, while UCP1-dependent proton transport, which also requires small molecules known as activators, is the basis of brown fat thermogenesis. Arachidonic acid (AA) is an endogenous activator capable of inducing proton transport in both proteins. As such, both AAC1- and UCP1-dependent proton transport are potential targets of weight loss drugs. While AAC1 structures have long been available, only recently have structures of UCP1 been determined. Unfortunately, no AA-bound structure of either protein is available. To explore their interactions with AA, we performed molecular dynamics (MD) simulations of both proteins. Six parallel simulations of each protein were run with an average length of just over 6 μs, for a total of 75 μs of aggregate simulation across both proteins. AA bound deeply between transmembrane helix (TM) helices or in the central cavity of AAC1 in 14 events and between TM helices of UCP1 in 6 events. All AA involved in these deep binding events came from the intermembrane space-facing (C) leaflet. In AAC1, AA most often bound between TM1/TM2 and TM5/TM6. In four cases the fatty acid bound at the bottom of the central cavity rather than in an interhelical groove. In UCP1, all but one deeply bound AA sat between TM5 and TM6. No AA fully entered the cavity as observed in AAC1. In addition to entering the proteins, AAs were enriched around them in the surrounding membrane adjacent to the TM helices. While both protein structures exhibit hydrophobic stretches separating the intermembrane space (IMS) from the matrix, water wires formed through both AAC1 and UCP1, connecting the bulk water in both regions. Grotthuss shuttling along water wires has been proposed as a possible mechanism of AAC1/UCP1-dependent proton transport, but water wires are not present in experimental structures and have not previously been reported in MD simulations. Calculations of electric potentials along these water wires find a large 0.75–1 V electrostatic barrier along water wires through AAC1 and a substantially smaller such barrier of ~0.5 V through UCP1.

28 April 2026 in ACS Chemical Biology
Verified
Journal Article
Open access
JMJohannes Morstein
Johannes Morstein
JBJonathan Haddad Borowsky
Jonathan Haddad Borowsky
SHShenghui Hu
Shenghui Hu
YSYooJin Sheen
YooJin Sheen
VNVictoria Nisoli
Victoria Nisoli
KSKevan M. Shokat
Kevan M. Shokat
Many therapeutically relevant membrane proteins possess druggable sites at the lipid-protein interface, but principles guiding ligand design for these sites are not well-defined. CFTR potentiators, a clinically validated drug class for cystic fibrosis, offer a compelling model for exploring membrane-targeted design principles, as their efficacy depends on sustained intramembrane binding to prolong channel opening and chloride conductance. Here, we systematically modified the lipophilic substituent of the CFTR potentiator ABBV-974 and identified an analog that confers markedly increased functional residence time, as measured by delayed current decay after compound washout in patch-clamp assays. Kinetic analysis incorporating the physicochemical properties of the lipophilic substituents suggests that this increased kinetic stability may arise from an increased residence time in the cell membrane, consistent with qualitative results of molecular dynamics simulations. These results establish a structure-function link between membrane-facing ligand modifications and functional target engagement and potentially offer generalizable strategies for designing probe molecules and drugs that stably engage lipid-exposed binding sites on membrane proteins.